BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,284,000 | +74.6% | 197,980 | +76.0% | 0.06% | +65.7% |
| Q3 2021 | $15,630,000 | +10.3% | 112,517 | -22.9% | 0.04% | +9.4% |
| Q2 2021 | $14,174,000 | +42.0% | 146,000 | 0.0% | 0.03% | +28.0% |
| Q1 2021 | $9,979,000 | -26.6% | 146,000 | -8.0% | 0.02% | -26.5% |
| Q4 2020 | $13,600,000 | +35.6% | 158,675 | +2.9% | 0.03% | +9.7% |
| Q3 2020 | $10,029,000 | -9.4% | 154,275 | +1.9% | 0.03% | -22.5% |
| Q2 2020 | $11,067,000 | +114.9% | 151,375 | 0.0% | 0.04% | +60.0% |
| Q1 2020 | $5,151,000 | +2101.3% | 151,375 | +3420.3% | 0.02% | +2400.0% |
| Q4 2019 | $234,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |